Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Rite Aid Corporation Common Stock (NY:RAD)

N/A UNCHANGED
Last Price Updated: 7:00 PM EDT, Oct 13, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Rite Aid Corporation Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
3 Strong Sell Stocks for September 2023
These 3 stocks to avoid aren't offering much right now – except uncertainty and massive risk of potential losses. 
Via InvestorPlace
12 Consumer Staples Stocks Moving In Friday's Pre-Market Session
Via Benzinga
FDA Panel Says Popular OTC Cold, Allergy Medicine Might Be Useless - Stocks To Watch
According to FDA panel experts who reviewed the latest research on the long-questioned phenylephrine, a drug ingredient used in several leading decongestants used by millions of Americans looking for... 
Via Benzinga
Exposures Product Safety
5 Stocks to Buy on a Potential Debt Avalanche
We could be on the brink of a debt avalanche as rates climb higher. To protect yourself and profit, consider these five stocks to buy. 
Via InvestorPlace
Rite Aid Short Squeeze Takes RAD Stock 6% Higher
Rite Aid has been on fire this week as RAD stock strings together a six-day win streak. The short squeeze has nearly caused shares to double. 
Via InvestorPlace
Why Shares of Rite Aid Soared This Week
The drugstore company may be benefiting from a short squeeze. 
Via The Motley Fool
Rite Aid (RAD) Q1 2024 Earnings Call Transcript
RAD earnings call for the period ending March 31, 2023. 
Via The Motley Fool
Top 5 Defensive Stocks That Could Blast Off This Quarter
The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
Why NovoCure Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers Mobile Infrastructure Corporation (NASDAQ: BEEP) shares jumped 98.7% to $12.02. 
Via Benzinga
What's Going On With Rite Aid (RAD) Stock?
Rite Aid Corporation (NYSE: RAD) shares are trading higher Monday. The stock appears to be rebounding after falling more than 50% on Friday. 
Via Benzinga
Why Are Stocks Up Today?
Stocks are up today and investors wondering why need look no further than a couple positive catalysts coming later this week. 
Via InvestorPlace
RAD Stock Alert: Will Rite Aid Be the Next Big Short Squeeze?
RAD stock sank 50% on Friday amid reports that Rite Aid will soon declare bankruptcy. Will RAD stock be the next short squeeze? 
Via InvestorPlace
Topics Bankruptcy
Exposures Financial Legal
MMM Stock Alert: The $5.5 Billion Reason 3M Is Up Today
3M (MMM) stock is on the rise Monday after reports claimed the company is closing in on a settlement over an earplugs lawsuit. 
Via InvestorPlace
Why Is Myomo (MYO) Stock Down 13% Today?
Myomo (MYO) stock is dropping on Monday after the wearable medical robotics company priced a $4.4 million public share offering. 
Via InvestorPlace
Why Is Rite Aid (RAD) Stock Down Today?
Rite Aid (RAD) stock is falling on Monday following reports that the pharmaceutical company is preparing to file for bankruptcy. 
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
We're starting off the week with a breakdown of the biggest pre-market stock movers worth reading about on Monday morning! 
Via InvestorPlace
RAD Stock Alert: Rite Aid Plunges on the Brink of Bankruptcy
Investors in Rite Aid appear to be fleeing for the exits, as RAD stock plunges 50% in today's session on very negative news. 
Via InvestorPlace
Rite Aid Once Top Drugstore Chain Lost Over 80% Of Stock Value In One Year: Opioid Litigation Takes Toll
Rite Aid Corp (NYSE: RAD) is reportedly on the brink of filing for bankruptcy amidst many lawsuits over its purported role in the opioid crisis to address its significant debt burden, which exceeds... 
Via Benzinga
Topics Bankruptcy Lawsuit
Exposures Financial Legal
Stocks That Hit 52-Week Lows On Wednesday
  Wednesday's session saw 150 companies set new 52-week lows. 
Via Benzinga
S&P Slashes Ratings Of Five US Banks, SEC Fines Fintech Adviser Titan For Misleading Crypto Claims, Microsoft Modifies Activision Blizzard Purchase: Today's Top Stories
Benzinga 
Via Benzinga
Topics Regulatory Compliance Stocks
Exposures Legal Regulatory US Equities
Gold Rush In Weight Loss Industry Impacts Retailers With Pharmacy Businesses
Retailers with pharmacy businesses, including major players like Walmart Inc (NYSE: WMT), Kroger Company (NYSE: KR), and Rite Aid Corp (NYSE: 
Via Benzinga
10 Consumer Staples Stocks Moving In Thursday's Intraday Session
Via Benzinga
TTOO vs. RAD Stock: Which New Meme Stock Is the Worst Buy?
Both Rite Aid and T2 Biosystems have enjoyed meme stock surges recently. Here's why TTOO is a better buy than RAD stock. 
Via InvestorPlace
Could Rite Aid Become the Next AMC Meme Stock?
Speculators are betting that Rite Aid could be the next AMC stock. Here's why RAD stands out now in the meme stocks world. 
Via InvestorPlace
Why Is Ballard Power (BLDP) Stock Up 7% Today?
Ballard Power Systems (BLDP) stock is getting a boost on Thursday after announcing a partnership with Ford (F) for hydrogen fuel cell tech. 
Via InvestorPlace
RUN Stock Price Prediction: Can Sunrun Really Rally 80% From Here?
Sunrun (RUN) stock is taking off on Thursday alongside earnings and a new price prediction from Janney Montgomery Scott analyst Thomas Meric. 
Via InvestorPlace
Is a Giant Short Squeeze Brewing in Rite Aid (RAD) Stock?
RAD stock is the third this week to head into a bankruptcy short squeeze. This "supernova" represents the imminent death of a once proud name. 
Via InvestorPlace
Is Affordable Insulin Available? Survey Reveals Uninsured Americans Paying More Despite Promised Price Reduction
According to a survey conducted by U.S. 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
  Wednesday's session saw 43 companies set new 52-week lows. 
Via Benzinga
Biden Administration Releases Revised Guidance For Medicare Drug Price Negotiation Amid Industry Lawsuits
The Centers for Medicare and Medicaid Services released revised guidance on using its authority with pharmaceutical manufacturers 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.